Skip to main content

Feiba VH Side Effects

Generic name: anti-inhibitor coagulant complex

Medically reviewed by Last updated on Jan 7, 2024.

Note: This document contains side effect information about anti-inhibitor coagulant complex. Some dosage forms listed on this page may not apply to the brand name Feiba VH.

Applies to anti-inhibitor coagulant complex: intravenous powder for solution.

Intravenous route (Powder for Solution)

Thromboembolic events have been reported during postmarketing surveillance following infusion of anti-inhibitor coagulant complex, particularly following the administration of high doses and/or in patients with thrombotic risk factors. Monitor patients receiving anti-inhibitor coagulant complex for signs and symptoms of thromboembolic events.

Serious side effects of Feiba VH

Along with its needed effects, anti-inhibitor coagulant complex (the active ingredient contained in Feiba VH) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking anti-inhibitor coagulant complex:

More common

Incidence not known

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.